Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where José M. Bueno is active.

Publication


Featured researches published by José M. Bueno.


Journal of Medicinal Chemistry | 2008

Synthesis and Structure-Activity Relationships of 4-Pyridones as Potential Antimalarials

Clive Yeates; John F. Batchelor; Edward C. Capon; Neil J. Cheesman; Mitch Fry; Alan Thomas Hudson; Mary Pudney; Helen Trimming; James Michael Woolven; José M. Bueno; Jesús Chicharro; Esther Fernández; Jose M. Fiandor; Domingo Gargallo-Viola; Federico Gómez de las Heras; Esperanza Herreros; María Luisa León

A series of diaryl ether substituted 4-pyridones have been identified as having potent antimalarial activity superior to that of chloroquine against Plasmodium falciparum in vitro and murine Plasmodium yoelii in vivo. These were derived from the anticoccidial drug clopidol through a systematic study of the effects of varying the side chain on activity. Relative to clopidol the most active compounds show >500-fold improvement in IC50 for inhibition of P. falciparum in vitro and about 100-fold improvement with respect to ED50 against P. yoelii in mice. These compounds have been shown elsewhere to act selectively by inhibition of mitochondrial electron transport at the cytochrome bc1 complex.


ACS Medicinal Chemistry Letters | 2011

An Invitation to Open Innovation in Malaria Drug Discovery: 47 Quality Starting Points from the TCAMS

Félix Calderón; David Barros; José M. Bueno; José M. Coterón; Esther Fernández; Francisco Javier Gamo; José L. Lavandera; María Luisa León; Simon J. F. Macdonald; Araceli Mallo; Pilar Manzano; Esther Porras; Jose M. Fiandor; Julia Castro

In 2010, GlaxoSmithKline published the structures of 13533 chemical starting points for antimalarial lead identification. By using an agglomerative structural clustering technique followed by computational filters such as antimalarial activity, physicochemical properties, and dissimilarity to known antimalarial structures, we have identified 47 starting points for lead optimization. Their structures are provided. We invite potential collaborators to work with us to discover new clinical candidates.


Tetrahedron Letters | 2000

Stereoselective synthesis of the antifungal GM222712

José M. Bueno; José M. Coterón; Jose Luis Chiara; Alfonso Fernández-Mayoralas; Jose M. Fiandor; Nuria Valle

Abstract An efficient and convergent synthesis of the antifungal agent GM222712 is described. The approach involves the preparation of the modified sugar moiety followed by its stereoselective anomeric O -alkylation with sordaricin triflate 19 .


Tetrahedron | 1994

Formation of mono- and di- nuclear complexes of Zn2+ from a 26 membered tetraester crown of 3,5-disubstituted pyrazole able to act as neutral and dianionic ligand

Carmen Acerete; José M. Bueno; Lucrecia Campayo; Pilar Navarro; M. Isabel Rodríguez-Franco; André Samat

Abstract A selective synthesis of bis(3,5-diketo-1H-pyrazole)-[26]crown- 12 ( 1 , L 1 ) has been performed. Its deprotonation pK a values, and those of the acyclic analogues ( 3 – 5 ) have been measured. The disodium dipyrazolate salt of 1 ( 2 , [L 2 ] 2- 2Na + ) has been isolated, and mono- and di- nuclear complexes of Zn 2+ obtained from 1 ([L 1 Zn] 2+ ) and 2 ([L 2 Zn 2 ] 2+ ) have been studied by 13 C NMR spectroscopy in DMSO-d 6 solution.


Bioorganic & Medicinal Chemistry Letters | 2011

Potent antimalarial 4-pyridones with improved physico-chemical properties.

José M. Bueno; Pilar Manzano; María del Carmen García; Jesús Chicharro; Margarita Puente; Milagros Lorenzo; Adolfo M. García; Santiago Ferrer; Rubén M. Gómez; María Teresa Fraile; José L. Lavandera; Jose M. Fiandor; Jaume Vidal; Esperanza Herreros; Domingo Gargallo-Viola

Antimalarial 4-pyridones are a novel class of inhibitors of the plasmodial mitochondrial electron transport chain targeting Cytochrome bc1 (complex III). In general, the most potent 4-pyridones are lipophilic molecules with poor solubility in aqueous media and low oral bioavailability in pre-clinical species from the solid dosage form. The strategy of introducing polar hydroxymethyl groups has enabled us to maintain the high levels of antimalarial potency observed for other more lipophilic analogues whilst improving the solubility and the oral bioavailability in pre-clinical species.


ACS Medicinal Chemistry Letters | 2014

Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives.

María J. Chaparro; Jaume Vidal; Iñigo Angulo-Barturen; José M. Bueno; Jeremy N. Burrows; Nicholas Cammack; Pablo Castañeda; Gonzalo Colmenarejo; José M. Coterón; Laura Fernández de las Heras; Esther Fernández; Santiago Ferrer; Raquel Gabarró; Francisco Javier Gamo; Mercedes García; María Belén Jiménez-Díaz; María J. Lafuente; María Luisa León; María Santos Martínez; Douglas J. Minick; Sara Prats; Margarita Puente; Lourdes Rueda; Elena Sandoval; Ángel Santos-Villarejo; Michael J. Witty; Félix Calderón

Antiparasitic oral drugs have been associated to lipophilic molecules due to their intrinsic permeability. However, these kind of molecules are associated to numerous adverse effects, which have been extensively studied. Within the Tres Cantos Antimalarial Set (TCAMS) we have identified two small, soluble and simple hits that even presenting antiplasmodial activities in the range of 0.4-0.5 μM are able to show in vivo activity.


Tetrahedron Letters | 1993

Synthesis of a stable dinuclear complex formed from a 26 membered proton-ionizable crown of 3,5-disusbstituted 1H-pyrazole and homoveratrylamine

Lucrecia Campayo; José M. Bueno; Carmen Ochoa; Pilar Navarro; André Samat

The 26 membered proton ionizable crown of 3.5-disubstituted 1H-pyrazole 1 acts as a synthetic receptor able to interac with the amino group common to neurotransmitter substrates, such as catecholamines. The synthesis of a solid and stable dinuclear complex formed by proton ionizable crown 1 and homoveratrylamines is described. The FAB mass apectrum of complex, and the difference found in 13C-RMN spectra of crown 1 and its dinuclear complex 3 we commented. The isolation of this dinuclear complex confirm the hypothesis that of synthetic receptor 1 is able to recognise catecholamines and to interact with the amno group of such amines.


Archive | 2011

7-pyrrolyl tetracycline compounds and methods of use thereof

Sophie Huss; José M. Bueno; Jose M. Fiandor; Roger Frechette


Journal of Organic Chemistry | 1997

A Proton-Ionizable Ester Crown of 3,5-Disubstituted 1H-Pyrazole Able To Form Stable Dinuclear Complexes with Lipophilic Phenethylamines.

Lucrecia Campayo; José M. Bueno; Pilar Navarro; Carmen Ochoa; Jesús Jiménez-Barbero; Gérard Pèpe; André Samat


Bioorganic & Medicinal Chemistry Letters | 2013

Corrigendum to “Potent antimalarial 4-pyridones with improved physico-chemical properties” [Bioorg. Med. Chem. Lett. 21 (2011) 5214–5218]

José M. Bueno; Pilar Manzano; María del Carmen García; Jesús Chicharro; Margarita Puente; Milagros Lorenzo; Adolfo M. García; Santiago Ferrer; Rubén M. Gómez; María Teresa Fraile; José L. Lavandera; Jose M. Fiandor; Jaume Vidal; Esperanza Herreros; Domingo Gargallo-Viola

Collaboration


Dive into the José M. Bueno's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Esther Fernández

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

José L. Lavandera

Complutense University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Lucrecia Campayo

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar

Pilar Navarro

Spanish National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge